Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 31st May 2017
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

FECAVA AND ESCCAP unite to tackle vector-borne diseases
A dog with leishmaniasis.

Organisations working to better inform companion animal vets

Two leading companion animal organisations are set to collaborate in the fight against vector-borne diseases in cats and dogs.

The Federation of Companion Animal Veterinary Associations (FECAVA) and the European Scientific Counsel for Companion Animal Parasites (ESCCAP) will meet at the WSAVA/FECAVA Congress in September.

The organisations will convene at the second meeting of the FECAVA working group on canine vector-borne diseases (CVBD). The group is working to better inform companion animal vets about emerging infectious diseases, such as heart worm, babesiosis and leishmaniasis.

Tools currently under development for veterinary practitioners by the group include algorithms, tables and travel advice for clients.

“Most companion animal veterinarians are insufficiently informed about these emerging diseases, and FECAVA has great potential to spread information on the distribution, diagnosis, treatment and prevention of these diseases to practitioners in all parts of Europe,” commented Nenad Milojkovic, chair of the FECAVA working group on canine vector-borne diseases.

Ian Wright, ESCCAP’s guidelines director, added: “It is vital that veterinary professionals have easy access to the latest detained consistent advice from experts to help them make informed treatment decisions.”

Researchers hope that the tools under development will help raise awareness of vector-borne diseases and assist in the clinical approach in endemic areas.

FECAVA and ESCCAP will also co-author a paper on drug resistance which, according to Ian Wright, is "one of the defining issues in livestock, equine and human parasite control.” 

“While resistance has been much slower to emerge in parasites of cats and dog, there are huge data gaps in our knowledge as to how widespread it might be currently, and how likely it might be to develop in the future,” he said.

Image (C) © Filipe Dantas-Torres / Wikimedia

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.